Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Total revenue	$ 3,487,496	$ 3,477,841	$ 10,017,264	$ 9,371,977
Operating expenses:
Patient expenses	361,141	428,615	1,042,504	1,213,799
Salaries and benefits	3,377,070	2,622,266	9,127,992	7,882,665
Share-based compensation	188,490	108,377	422,266	311,406
Advertising and marketing	294,046	234,694	875,123	650,861
Grant funds				(415,978)
General and administrative	1,603,056	961,521	4,483,587	3,406,116
Depreciation and amortization	450,579	430,121	1,314,584	1,334,267
Total operating expenses	6,274,382	4,785,594	17,266,056	14,383,136
Operating loss	(2,786,886)	(1,307,753)	(7,248,792)	(5,011,159)
Other income (expense):
Interest income	1,754	6,028	1,754	6,067
Other income		6	135	6
Gain (loss) on extinguishment of debt		9,783	108	(99,761)
Gain on lease modification	57,086		57,086
Loss on disposal of assets	(56,270)	(39,047)	(60,264)	(60,272)
Interest expense	(108,315)	(141,416)	(410,822)	(352,541)
Total other expenses	(105,745)	(164,646)	(412,003)	(506,501)
Net loss before income taxes	(2,892,631)	(1,472,399)	(7,660,795)	(5,517,660)
Income taxes
Net loss	(2,892,631)	(1,472,399)	(7,660,795)	(5,517,660)
Net loss attributable to the non-controlling interest	1,171,895	42,741	1,953,980	323,769
Net loss attributable to IMAC Holdings, Inc.	$ (1,720,736)	$ (1,429,658)	$ (5,706,815)	$ (5,193,891)
Net loss per share attributable to common stockholders
Basic and diluted	$ (0.07)	$ (0.12)	$ (0.27)	$ (0.49)
Weighted average common shares outstanding
Basic and diluted	25,322,356	11,839,972	21,446,726	10,549,899
Health Care, Patient Service [Member]
Total revenue	$ 3,487,482	$ 3,477,841	$ 9,975,104	$ 9,359,490
Other income [member]
Total revenue	14		6,092
Management Service [Member]
Total revenue			$ 36,068	$ 12,487